Sanjivani Paranteral Ltd Annual Report FY26 Released
Sanjivani Paranteral Ltd has released its Annual Report for the Financial Year 2025-26, detailing its performance and strategic outlook. The report highlights a 'Stronger Performance, Sustainable Growth, and Shared Success' driven by innovation and a commitment to excellence in care. The company expanded its global footprint across Latin America, Central America, the Middle East, and Francophone Africa, supported by new regulatory approvals. FY27 is anticipated to be pivotal with the simultaneous contribution of its base business, SPL Infusion Pvt. Ltd. (IV infusions), and Alevia Healthcare S.R.O. (nutraceuticals), aiming to drive scale, diversification, and resilience. The report is available on the company's website.
Key Highlights
- Annual Report for FY25-26 released, focusing on performance and growth.
- Expanded global presence in Latin America, Middle East, and Africa.
- FY27 to see combined contribution from base business, IV infusions, and nutraceuticals.
- Strategic joint ventures are laying groundwork for future growth phases.
- Commitment to patient-centric solutions and stakeholder value creation.
Price Impact
More from SANJIVIN